To stimulate innovation and entrepreneurship in both education and research IXA has, in collaboration with the City of Amsterdam, developed the valorisation program IXAnext; Talent for Innovation. All Amsterdam universities and knowledge institutes are involved: HvA, UvA, VU, Amsterdam UMC and the NWO institutes AMOLF and NIKHEF. In a five year periode, 2017-2021, they collaborate in utilizing and disseminate knowledge and stimulate economic activity and entrepreneurship. All for the greater good and benefit of Amsterdams research and entrepreneurial ecosystem.
Benefits for researchers, teachers, students, entrepreneurs, companies… for who not?
The program offers facilities and funding, infrastructure, educational measures, a network and much more. Researchers, teachers and students have the incubators Amsterdam Venture Studios and Demonstrator Lab at their disposal to develop and test their business cases or accommodate their start-up activities.
Companies and non profits can benefit from the latest scientific expertise and research facilities with the Physics on Demand service. The Research Facilities database helps R&D departments to find specialized, high end equipment and instruments.
Teachers in Entrepreneurship can find inspiration for their education program and lessons with the Entrepreneurship cases and the pilot Blended Learning.
Students with plans for a start-up can profit from the knowledge of mentors found through the platform Startup and Running.
It is save to state IXAnext offers something for everyone.
Jaap Bonjer (Amsterdam UMC), Erwin Peterman en Gijs Wuite (VU) en Roeland van Geuns (HvA) ontvangen de Impact Awards 2019. De Amsterdamse Impact Award wordt ieder jaar toegekend aan gerenommeerde onderzoekers of onderzoeksgroepen, die met hun onderzoek en innovaties een betekenisvolle bijdrage hebben geleverd aan de maatschappij. De Award is een lifetime achievement award en […]News
We are very happy to announce that the call for Amsterdam UMC TKI-PPP grants is now open. For the first time the TKI grant procedures from AMC and VUmc will be combined (now that VUmc has also been allowed by Health~Holland to evaluate its own projects)! This means that the grant amounts available to both […]News
Azafaros, a biotech company established in Leiden in the Netherlands, focusing on the development of new therapies in the field of rare metabolic disorders, announced the closing of a seed financing round. BioGeneration Ventures (BGV) is the founding investor. Rare metabolic disorders such as lysosomal storage disorders (LSDs) represent a broad class of severe and […]News